The Company is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia. The Company was established on December 09, 2011. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on May 28, 2019.
Headquarters
216, 187, Techno 2-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;
Contact Details: Purchase the Sugentech, Incorporate report to view the information.
Website: http://www.sugentech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service